Identification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of Brazil.
Amanda C CamargoUrsula MatteMariana Rodrigues BottonPublished in: Expert opinion on drug safety (2023)
Relevant amount of ADRs were related to drugs with pharmacogenetic recommendations on drug labels and/or guidelines. Genetic information could guide and improve clinical outcomes, decreasing ADR incidence and reducing treatment costs.